Sterile Injectable Drugs Market Scope and Size by 2031
Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body. These preparations are administered by injection, infusion, or implantation in the body with the help of a needle, syringe, or implantable devices.
MARKET DYNAMICS
The sterile injectable drugs market is driving due to the growing prevalence of chronic diseases and cancer and the increasing demand for cell therapies for the treatment of these diseases. However, the high cost of devices, stringent regulations, and lack of skilled personnel with sound technical know-how is likely to restraint the market growth during the forecast period. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research funding contribute to the growth of the market for sterile injectable drugs.
MARKET SCOPE
The "Sterile Injectable Drugs Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of sterile injectable drugs market with detailed market segmentation by product, technology, application and end user. The sterile injectable drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in sterile injectable drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The sterile injectable drugs market is segmented on the basis of application. On the basis of application, the market is categorized as cancer, diabetes, cardiovascular diseases, musculoskeletal, CNS, infections and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the sterile injectable drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sterile injectable drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting sterile injectable drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sterile injectable drugs market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the sterile injectable drugs market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The sterile injectable drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting sterile injectable drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the sterile injectable drugs market in these regions.
MARKET PLAYERS
The report covers key developments in the sterile injectable drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from sterile injectable drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for sterile injectable drugs in the global market. Below mentioned is the list of few companies engaged in the sterile injectable drugs market.
The report also includes the profiles of key players in sterile injectable drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- AstraZeneca Plc.
- Baxter International Inc.
- GILEAD SCIENCES, INC.
- GlaxoSmithKline plc.
- hameln group gmbh
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Sterile Injectable Drugs Market - By Applications
1.3.2 Sterile Injectable Drugs Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. STERILE INJECTABLE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. STERILE INJECTABLE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. STERILE INJECTABLE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. STERILE INJECTABLE DRUGS - GLOBAL MARKET OVERVIEW
6.2. STERILE INJECTABLE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. STERILE INJECTABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATIONS
7.1. OVERVIEW
7.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
7.3. CANCER
7.3.1. Overview
7.3.2. Cancer Market Forecast and Analysis
7.4. DIABETES
7.4.1. Overview
7.4.2. Diabetes Market Forecast and Analysis
7.5. CARDIOVASCULAR DISEASES
7.5.1. Overview
7.5.2. Cardiovascular Diseases Market Forecast and Analysis
7.6. MUSCULOSKELETAL
7.6.1. Overview
7.6.2. Musculoskeletal Market Forecast and Analysis
7.7. CNS
7.7.1. Overview
7.7.2. CNS Market Forecast and Analysis
7.8. INFECTIONS
7.8.1. Overview
7.8.2. Infections Market Forecast and Analysis
7.9. OTHERS
7.9.1. Overview
7.9.2. Others Market Forecast and Analysis
8. STERILE INJECTABLE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Sterile Injectable Drugs Market Overview
8.1.2 North America Sterile Injectable Drugs Market Forecasts and Analysis
8.1.3 North America Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.1.4 North America Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.1.4.1 United States Sterile Injectable Drugs Market
8.1.4.1.1 United States Sterile Injectable Drugs Market by Applications
8.1.4.2 Canada Sterile Injectable Drugs Market
8.1.4.2.1 Canada Sterile Injectable Drugs Market by Applications
8.1.4.3 Mexico Sterile Injectable Drugs Market
8.1.4.3.1 Mexico Sterile Injectable Drugs Market by Applications
8.2. EUROPE
8.2.1 Europe Sterile Injectable Drugs Market Overview
8.2.2 Europe Sterile Injectable Drugs Market Forecasts and Analysis
8.2.3 Europe Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.2.4 Europe Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Sterile Injectable Drugs Market
8.2.4.1.1 Germany Sterile Injectable Drugs Market by Applications
8.2.4.2 France Sterile Injectable Drugs Market
8.2.4.2.1 France Sterile Injectable Drugs Market by Applications
8.2.4.3 Italy Sterile Injectable Drugs Market
8.2.4.3.1 Italy Sterile Injectable Drugs Market by Applications
8.2.4.4 Spain Sterile Injectable Drugs Market
8.2.4.4.1 Spain Sterile Injectable Drugs Market by Applications
8.2.4.5 United Kingdom Sterile Injectable Drugs Market
8.2.4.5.1 United Kingdom Sterile Injectable Drugs Market by Applications
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Sterile Injectable Drugs Market Overview
8.3.2 Asia-Pacific Sterile Injectable Drugs Market Forecasts and Analysis
8.3.3 Asia-Pacific Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.3.4 Asia-Pacific Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Sterile Injectable Drugs Market
8.3.4.1.1 Australia Sterile Injectable Drugs Market by Applications
8.3.4.2 China Sterile Injectable Drugs Market
8.3.4.2.1 China Sterile Injectable Drugs Market by Applications
8.3.4.3 India Sterile Injectable Drugs Market
8.3.4.3.1 India Sterile Injectable Drugs Market by Applications
8.3.4.4 Japan Sterile Injectable Drugs Market
8.3.4.4.1 Japan Sterile Injectable Drugs Market by Applications
8.3.4.5 South Korea Sterile Injectable Drugs Market
8.3.4.5.1 South Korea Sterile Injectable Drugs Market by Applications
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Sterile Injectable Drugs Market Overview
8.4.2 Middle East and Africa Sterile Injectable Drugs Market Forecasts and Analysis
8.4.3 Middle East and Africa Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.4.4 Middle East and Africa Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Sterile Injectable Drugs Market
8.4.4.1.1 South Africa Sterile Injectable Drugs Market by Applications
8.4.4.2 Saudi Arabia Sterile Injectable Drugs Market
8.4.4.2.1 Saudi Arabia Sterile Injectable Drugs Market by Applications
8.4.4.3 U.A.E Sterile Injectable Drugs Market
8.4.4.3.1 U.A.E Sterile Injectable Drugs Market by Applications
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Sterile Injectable Drugs Market Overview
8.5.2 South and Central America Sterile Injectable Drugs Market Forecasts and Analysis
8.5.3 South and Central America Sterile Injectable Drugs Market Forecasts and Analysis - By Applications
8.5.4 South and Central America Sterile Injectable Drugs Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Sterile Injectable Drugs Market
8.5.4.1.1 Brazil Sterile Injectable Drugs Market by Applications
8.5.4.2 Argentina Sterile Injectable Drugs Market
8.5.4.2.1 Argentina Sterile Injectable Drugs Market by Applications
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL STERILE INJECTABLE DRUGS MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Rest of the World
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. STERILE INJECTABLE DRUGS MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA PLC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAXTER INTERNATIONAL INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GILEAD SCIENCES, INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HAMELN GROUP GMBH
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JOHNSON AND JOHNSON SERVICES, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO., INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. AstraZeneca Plc.
2. Baxter International Inc.
3. GILEAD SCIENCES, INC.
4. GlaxoSmithKline plc.
5. hameln group gmbh
6. Johnson & Johnson Services, Inc.
7. Merck & Co., Inc.
8. Novartis AG
9. Pfizer Inc.
10. Sanofi
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For